The results showed that the expression of NKILA was significantly downregulated in tumor tissues compared with the adjacent normal tissues in these 106 NSCLC patients (p < 0.001, Fig. 1a and b). The gene discussed is NKILA; the disease is non-small cell lung carcinoma.